Latest Zopiclone Stories
Study Addresses Key Question Raised in Regulatory Review; Flibanserin New Drug Application to be Resubmitted Q1 2015 RALEIGH, N.C., Nov.
NORTH KINGSTOWN, R.I., Sept.
On May 15, the FDA warned that Eszopiclone Containing Sleep Aids (including Lunesta and generics) can cause next-day impairment of driving and other activities that require alertness.
Commonly prescribed sleeping pills/sedatives may increase the risk of contracting pneumonia by as much as 50% and increase the risk of dying from it.
Tokyo, Apr 17, 2012 - (JCN Newswire) - Eisai Co., Ltd.
Tokyo, Jan 18, 2012 - (JCN Newswire) - Eisai Co.
POINT RICHMOND, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced its preliminary analysis of data from the recently completed IntermezzoÂ® 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.
WALTHAM, Mass., Jan.
US-based pharmaceutical company Sepracor has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion recommending to grant a marketing authorization for Lunivia brand eszopiclone in the EU for the treatment of insomnia.